SCHEMBL3872525

SCHEMBL3872525

CN(C)S(=O)(=O)Nc1ccc(O)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 8/20 0.68
MEN1 O00255 1/20 0.68
KMT2A Q03164 1/20 0.68
POLB P06746 2/20 0.58
HTT P42858 3/20 0.56
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
KIF11 P52732 1/20 0.54
AR P10275 1/20 0.54
ALDH1A1 P00352 4/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
THRB P10828 1/20 0.50
ALOX15 P16050 1/20 0.50
CASP1 P29466 1/20 0.50
RECQL P46063 1/20 0.50
HIF1A Q16665 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GAA P10253 3/20 0.47
GFER P55789 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11000743 0.89 HPGD (0.83) HPGDMEN1KMT2APOLBHTT
SCHEMBL3467606 0.81 HPGD (1.00) HPGDMEN1KMT2APOLBHTT
SCHEMBL5886620 0.79 HPGD (0.68) HPGDMEN1KMT2APOLBHTT
SCHEMBL9464414 0.79 HPGD (0.68) HPGDMEN1KMT2APOLBHTT
SCHEMBL14358427 0.79 HPGD (0.68) HPGDMEN1KMT2APOLBHTT
SCHEMBL14358426 0.79 HPGD (0.68) HPGDMEN1KMT2APOLBHTT
SCHEMBL11678919 0.79 HPGD (0.70) HPGDMEN1KMT2APOLBHTT
SCHEMBL8266737 0.79 HPGD (0.70) HPGDMEN1KMT2APOLBHTT
SCHEMBL5779314 0.79 HPGD (0.71) HPGDMEN1KMT2APOLBHTT
SCHEMBL460093 0.78 HPGD (0.70) HPGDMEN1KMT2APOLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601856-B2 Benzofurans as potassium ion channel modulators WYETH (US) 2009-10-13 US disclosed
US-7601856-B2 Benzofurans as potassium ion channel modulators WYETH (US) 2009-10-13 US disclosed
US-7601856-B2 Benzofurans as potassium ion channel modulators WYETH (US) 2009-10-13 US disclosed
US-20080027049-A1 Such as 2,2-Dimethyl-N-(6,7,8,9-tetrahydro-dibenzofuran-2-yl)-propionamide WYETH (US) 2008-01-31 US disclosed
US-20080027049-A1 Such as 2,2-Dimethyl-N-(6,7,8,9-tetrahydro-dibenzofuran-2-yl)-propionamide WYETH (US) 2008-01-31 US disclosed
US-20080027049-A1 Such as 2,2-Dimethyl-N-(6,7,8,9-tetrahydro-dibenzofuran-2-yl)-propionamide WYETH (US) 2008-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027049-A1 Such as 2,2-Dimethyl-N-(6,7,8,9-tetrahydro-dibenzofuran-2-yl)-propionamide KCNJ2, KCNJ5, KCNA5 HPGD 827/4885MEN1 1122/4885KMT2A 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.